Akut limfoid leukémia (ALL): vizsgálatok itt: Olaszország
35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Genoa, Meldola, Milan, Pisa, Rome, Turin
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Milan, Rome, Turin
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Bergamo, Bologna, Genoa, Rome, Turin
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - No phaseTaking peopleEstablishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
- Where
- Monza, Padova
- People
- 150 worldwide
- Run by
- Fondazione Matilde Tettamanti Menotti De Marchi Onlus
See details and how to joinNCT07899840 - 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Ancona, Bari, Bergamo, Bologna, Cagliari, Catania, Florence, Genoa, Monza, Naples, Padova, Palermo, Pavia, Rome, San Giovanni Rotondo, Trieste, Turin, Verona
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Bologna, Ravenna
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 1. fázisTaking peopleAllogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
- Where
- Rome
- Életkor
- 1 év to 35 év
- People
- 24
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT06080191 - 2/3. fázisTaking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Roma
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Cosenza, Florence, Genoa, Monza, Naples, Padova, Palermo, Parma, Pavia, Rome, Trieste, Turin, Verona
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 3. fázisTaking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Brescia, Candiolo, Catania, Florence, Milan, Rome, Varese
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Bergamo, Bologna, Meldola, Monza, Naples, Rome
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome, Torino
- Életkor
- 1 év to 17 év
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Bologna, Meldola, Milan, Rome, Vicenza
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1/2. fázisNot yet taking people in OlaszországStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Genoa, Monza, Rome
- Életkor
- Up to 64 év
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 · EU 2025-522019-40-00 - 1/2. fázisTaking peoplePhase I/II study of anti-CD7 Chimeric Antigen Receptor-Expressing T cells in pediatric patients/young adult affected by relapsed/refractory CD7+ T-cell Acute Lymphoblastic Leukemia/Lymphoma
- Where
- Rome
- Életkor
- Up to 64 év
- People
- 26
- Run by
- Ospedale Pediatrico Bambino Gesu'
See details and how to join2023-508355-39-00 · EU 2023-508355-39-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Bologna, Catania, Genova, Monza, Naples, Padova, Palermo, Pavia, Rome, Torino, Trieste
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 2/3. fázisTaking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Monza, Pavia, Rome
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - No phaseTaking peopleNovel Therapeutic Approach for Human T-cell Malignancies
- Where
- Naples, Padova
- Életkor
- 18 év and over
- People
- 120
- Run by
- Istituto Oncologico Veneto IRCCS
See details and how to joinNCT06600568 - 1/2. fázisTaking peopleInotuzumab ozogamicin for Acute Lymphoblastic Leukemia
- Where
- Monza, Rome, Turin
- Életkor
- Up to 17 év
- People
- 142 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 · EU 2023-504694-20-00 - 1. fázisTaking peoplePhase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of children and young adult with relapsed/refractory B-cell Acute Lymphoblastic Leukemia
- Where
- Rome
- Életkor
- Up to 64 év
- People
- 24
- Run by
- Ospedale Pediatrico Bambino Gesu'
See details and how to join2023-508420-36-00 · EU 2023-508420-36-00 - 3. fázisTaking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Ancona, Bari, Bergamo, Catania, Catanzaro, Cosenza, Florence, Genoa, Modena, Monza, Naples, Padova, Palermo, Parma, Perugia, Pescara, Rome, San Giovanni Rotondo, Trieste, Turin, Verona
- Életkor
- Up to 64 év
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00 - No phaseTaking peopleBio-CAR-T BS Study
- Where
- Brescia
- Életkor
- 18 év to 70 év
- People
- 45
- Run by
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
See details and how to joinNCT05366569 - 3. fázisTaking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Bologna, Meldola, Milan, Monza, Ravenna, Rome, Turin, Varese
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome, Turin
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Ancona, Bologna, Cagliari, Genoa, Monza, Naples, Palermo, Parma, Perugia, Rome, Trieste, Turin, Verona
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00